Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Human Microbiome Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


 

Human Microbiome Market Trends and Forecast

The future of the global human microbiome market looks promising with opportunities in the healthcare industry. The global human microbiome market is expected to reach an estimated $2.5 billion by 2028 with a CAGR of 17.8% from 2024 to 2030.The major drivers for this market are increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing.
  • Lucintel forecasts that probiotics will remain the largest segment over the forecast period due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.
  • Infectious disease will remain the largest disease type over the forecast period due to increasing cognizance of the negative effects of antibiotic use on the natural flora (such as disruptions), which has highlighted the need for specific bacterial-targeted therapies for infectious diseases.
  • North America will remain the largest region over the forecast period due to increasing incidence of lifestyle-related diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products. APAC is expected to witness the highest growth over the forecast period due rising chronic diseases caused by changes in lifestyle and growing interest in human microbiome treatment approaches.
Human Microbiome Market by Product, Disease Type, Research Technology, and Application
 

North America will remain the largest region in the Human Microbiome Market

  1. United States: Companies like uBiome and Seres Therapeutics are pioneering microbiome-based therapies for various diseases. Government initiatives such as the National Microbiome Initiative support research and development in microbiome science. 
  2. China: Chinese companies like Microbiota Biotech and WuXi AppTec are investing in microbiome research and therapeutic development. Government funding for microbiome research projects drives market growth. 
  3. Germany: German firms like Biovis Diagnostik and Biotype Innovation are focusing on microbiome diagnostics and therapeutics. Government initiatives promoting biotechnology innovation support market development.
  4. Japan: Japanese companies such as Microbiome Therapeutics Japan and Yakult Honsha Co. are exploring microbiome-based therapies. Government support for healthcare innovation accelerates market growth. 
  5. United Kingdom: UK companies like Microbiotica and 4D Pharma are advancing microbiome research and therapeutic applications. Government funding for microbiome-related projects and collaborations drives market expansion. 

Emerging Trends in the Human Microbiome Market

Emerging trends, which have a direct impact on the dynamics of the industry, include usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity.
A total of 119 figures / charts and 99 tables are provided in this 209-page report to help in your business decisions. A sample figure with some insights is shown below. 
Human Microbiome Market by Segments
 

Human Microbiome Market by Segment

In this market, therapeutics is the largest application market, whereas probiotics is the largest market by product type.
The study includes trends and forecast for the global human microbiome market by product, disease type, research technology, application, and region as follows:

Human Microbiome By Product [Value ($M) from 2018 to 2030]:

Human Microbiome By Disease Type [Value ($ Million) from 2018 to 2030]:

  • Infectious
  • Metabolic/ Endocrine
  • Cancer
  • Blood
  • Neurological

Human Microbiome By Research Technology [Value ($ Million) from 2018 to 2030]:

Human Microbiome By Application [Value ($ Million) from 2018 to 2030]:

Human Microbiome By Region [Value ($ Million from 2018 to 2030]:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
  • APAC
  • ROW
    • Brazil

List of Human Microbiome Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies human microbiome companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the human microbiome companies profiled in this report include.

Recent Developments in Human Microbiome Market 

  1. Advancements in Microbiome-based Therapies: Recent developments in the human microbiome market include advancements in microbiome-based therapies for various medical conditions. Companies like Seres Therapeutics and Rebiotix are developing microbiome-based drugs and fecal microbiota transplant (FMT) products targeting conditions such as Clostridioides difficile infection, inflammatory bowel disease, and metabolic disorders, offering potential alternatives to traditional treatments.
  2. Integration of Microbiome Analysis in Precision Medicine: The integration of microbiome analysis in precision medicine is expanding the understanding of disease mechanisms and personalized treatment approaches. Research institutions and companies are leveraging advanced sequencing technologies and bioinformatics tools to study the human microbiome's role in health and disease, paving the way for microbiome-based diagnostics, prognostics, and therapeutics.
  3. Emergence of Microbiome-friendly Consumer Products: The market for microbiome-friendly consumer products is growing, driven by consumer interest in products that support a healthy microbiome. Companies like Seed Health and Pendulum Therapeutics are launching probiotics, prebiotics, and microbiome-friendly supplements targeting gut health, skin care, and immune support, catering to consumers seeking wellness solutions informed by microbiome science. 
  4. Regulatory Approvals for Microbiome-based Therapeutics: Regulatory agencies are granting approvals for microbiome-based therapeutics, validating their safety and efficacy for clinical use. Products such as fecal microbiota transplants (FMT) and microbiome modulating drugs are receiving regulatory clearance for specific indications, providing healthcare providers and patients with new treatment options backed by scientific evidence. 
  5. Investments in Microbiome Research and Development: There's a significant increase in investments in microbiome research and development by pharmaceutical companies, biotechnology firms, and venture capital investors. Funding is fueling the discovery of novel microbiome targets, development of microbiome-based therapies, and expansion of clinical trials to evaluate their efficacy in treating a wide range of diseases and disorders. 
  6. Collaborations and Partnerships in Microbiome Science: Collaboration and partnerships between academia, industry, and government organizations are driving progress in microbiome science. Consortia such as the American Gut Project and the Human Microbiome Project are fostering interdisciplinary research collaborations, data sharing initiatives, and knowledge exchange platforms to advance our understanding of the human microbiome and its implications for health and disease. 

Features of the Human Microbiome Market

  • Market Size Estimates: Global human microbiome market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments.
  • Segmentation Analysis: Global human microbiome market size by product, disease type, research technology, application, and region in terms of value.
  • Regional Analysis: Global human microbiome market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, disease type, research technology, application, and region for the global human microbiome market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global human microbiome market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the human microbiome market size?
Answer: The global human microbiome market is expected to reach an estimated $2.5 billion by 2028.
Q2. What is the growth forecast for human microbiome market?
Answer: The human microbiome market is expected to grow at a CAGR of 17.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the human microbiome market?
Answer: The major drivers for this market are increasing focus on human microbiome therapies and technological advancements in metagenomics and next-generation sequencing.
Q4. What are the major applications or end use industries for human microbiome?
Answer: Therapeutics and Diagnostics are the major applications for human microbiome
Q5. What are the emerging trends in human microbiome market?
Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity.
Q6. Who are the key human microbiome companies?
Answer: Some of the key human microbiome companies are as follows:
  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Merck & Co.
  • Second Genome
  • Metabiomics Corporation
Q7.Which human microbiome product segment will be the largest in future?
Answer: Lucintel forecasts that probiotics will remain the largest product segment over the forecast period due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.
Q8: In human microbiome market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region and Asia Pacific expected to witness the highest growth over next 5 years.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
 

This report answers following 11 key questions

Q.1 What are some of the most promising growth opportunities for the global human microbiome market by product (prebiotics, probiotics, food, medical food, and drugs), disease type (infectious, metabolic/endocrine, cancer, blood, and neurological), research technology (proteomics, metabolomics, and genomics), application (therapeutics and diagnostics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global human microbiome market?
Q.5 What are the business risks and threats to the global human microbiome market?
Q.6 What are the emerging trends in this human microbiome market and the reasons behind them?
Q.7 What are some changing demands of customers in the human microbiome market?
Q.8 What are the new developments in the human microbiome market? Which companies are leading these developments?
Q.9 Who are the major players in the human microbiome market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the human microbiome market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global human microbiome market?

For any questions related to human microbiome market or related to human microbiome market share, human microbiome market analysis, and human microbiome market size, write to Lucintel analysts at helpdesk@lucintel.com. We will be glad to get back to you soon.
 
Table of Contents
1. Executive Summary
 
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends and Forecast
3.2: Global Human Microbiome Market Trends and Forecast
3.3: Global Human Microbiome Market by Product
3.3.1: Prebiotics 
3.3.2: Probiotics
3.3.3: Food
3.3.4: Medical Food
3.3.5: Drugs
3.4: Global Human Microbiome Market by Disease Type
3.4.1: Infectious
3.4.2: Metabolic/Endocrine
3.4.3: Cancer
3.4.4: Blood
3.4.5: Neurological
3.5: Global Human Microbiome Market by Research Technology
3.5.1: Proteomics
3.5.2: Metabolomics
3.5.3: Genomics
3.6: Global Human Microbiome Market by Application
3.6.1: Therapeutics
3.6.2: Diagnostics

4. Market Trends and Forecast Analysis by Region
4.1: Global Human Microbiome Market by Region
4.2: North American Human Microbiome Market
4.2.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.2.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.2.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.2.4: Market by Application: Therapeutics and Diagnostics
4.2.5: The US Human Microbiome Market
4.2.6: Canadian Human Microbiome Market
4.2.7: Mexican Human Microbiome Market
4.3: European Human Microbiome Market
4.3.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.3.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.3.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.3.4: Market by Application: Therapeutics and Diagnostics
4.3.5: Human Microbiome Market of the United Kingdom
4.3.6: German Human Microbiome Market
4.3.7: French Human Microbiome Market
4.3.8: Italian Human Microbiome Market
4.3.9: Spanish Human Microbiome Market
4.4: APAC Human Microbiome Market
4.4.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.4.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.4.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.4.4: Market by Application: Therapeutics and Diagnostics
4.4.5: Chinese Human Microbiome Market
4.4.6: Japanese Human Microbiome Market
4.4.7: Indian Human Microbiome Market
4.5: ROW Human Microbiome Market
4.5.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
4.5.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
4.5.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
4.5.4: Market by Application: Therapeutics and Diagnostics
4.5.5: Brazilian Human Microbiome Market

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Geographical Reach
5.4: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Human Microbiome Market by Product
6.1.2: Growth Opportunities for the Global Human Microbiome Market by Disease Type
6.1.3: Growth Opportunities for the Global Human Microbiome Market by Research Technology
6.1.4: Growth Opportunities for the Global Human Microbiome Market by Application
6.1.5: Growth Opportunities for the Global Human Microbiome Market by Region
6.2: Emerging Trends in the Global Human Microbiome Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Human Microbiome Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Microbiome Market

7. Company Profiles of Leading Players
7.1: Enterome
7.2: Seres Therapeutics
7.3: 4D Pharma
7.4: DuPont
7.5: Vedanta Biosciences
7.6: Osel
7.7: Yakult Hoshna
7.8: Merck & Co
7.9: Second Genome
7.10: Metabiomics Corporation
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030] Full Report $ 4,850
119 figures / charts and 99 tables are provided in this 209-page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Human Microbiome Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?